| 查看: 300 | 回复: 0 | |||
lubenle至尊木虫 (职业作家)
|
[交流]
FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用
|
|
Use of Aspirin for Primary Prevention of Heart Attack and Stroke http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm390574.htm FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用， 但对于有心脏病或中风史的人服用阿斯匹灵有预防再次发作的作用！ [05/02/2014] Cardiovascular disease, including heart disease and stroke, affects tens of millions of people in the United States. Consumers and patients who do not suffer from cardiovascular disease sometimes consider taking aspirin to reduce the possibility of having a heart attack or stroke. Reducing the possibility of having a first heart attack or stroke is called primary prevention. The FDA has reviewed the available data and does not believe the evidence supports the general use of aspirin for primary prevention of a heart attack or stroke. In fact, there are serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain, in situations where the benefit of aspirin for primary prevention has not been established. The available evidence supports the use of aspirin for preventing another heart attack or stroke in patients who have cardiovascular disease or who have already had a heart attack or stroke. Reducing the risk of additional heart attacks or strokes is known as secondary prevention. In patients who have had a cardiovascular event, the known benefits of aspirin for secondary prevention outweigh the risk of bleeding. |
回复此楼» 猜你喜欢
“正在承担的与本项目相关的科研项目情况”填不填挂名项目？
已经有12人回复
-
细胞生物学333分求调剂
已经有0人回复
-
内分泌系统/代谢和营养支持论文润色/翻译怎么收费?
已经有95人回复
-
25 申 博
已经有23人回复
-
求导师推荐 夏令营提前联系导师
已经有0人回复
-
广州医生科院申博复试笔试真题
已经有3人回复
-
投稿后主编给拒了但是说可以重写后再投
已经有8人回复
-
中科院2区Top期刊IJBM（IF=8.5）征稿-截止到4月底
已经有33人回复
